Maryland Psychiatric Research Center, University of Maryland School of Medicine, Baltimore, MD, United States.
Schizophr Res. 2012 Jul;138(2-3):285-9. doi: 10.1016/j.schres.2012.03.024. Epub 2012 May 10.
Up to 50-90% of persons with schizophrenia smoke cigarettes. Limited data and theories suggest persons with schizophrenia may smoke for different reasons than persons without schizophrenia, making smoking cessation interventions particularly challenging in this population. Although health consequences of smoking are widely known, less information is available regarding characteristics of different amounts of smoking exposure in this population. This study was performed to investigate differences between heavy (≥ 1 pack per day) and non-heavy (<1 pack per day) smoking in patients with schizophrenia. Data from 745 patients, mean age 41.3+/-12.6 years, were drawn from a population of smokers admitted to State of Maryland inpatient mental health facilities (1994-2000). Records were reviewed to obtain demographic information, diagnosis, medication, smoking and substance use. 43% of patients were characterized as heavy smokers. Heavy and non-heavy groups did not differ in age, GAF, weight, or BMI. No differences were found in race, gender or antipsychotic treatments. However, patients smoking ≥ 1 packs per day were more likely to use other substances such as alcohol (χ(2)=6.67, df=1, p=0.01), cocaine (χ(2)=6.66, df=1, p=0.01), and other substances (χ(2)=9.95, df=1, p=0.003) compared to non-heavy smokers. No differences in cannabis or heroin use were found by smoking category. Controlling for age, race, sex and BMI, heavy smokers had higher total cholesterol (190.7(51.6)mg/dL) compared to non-heavy smokers (178.2 (43.0)mg/dL, p=0.03), but no differences were found in glucose or blood pressure. Heavy smoking may be a particular health risk in schizophrenia and significant efforts for smoking cessation or reduction are needed.
高达 50-90%的精神分裂症患者吸烟。有限的数据和理论表明,精神分裂症患者可能出于与非精神分裂症患者不同的原因吸烟,这使得在该人群中进行戒烟干预特别具有挑战性。尽管吸烟的健康后果广为人知,但关于该人群中不同吸烟量的特征的信息较少。本研究旨在调查精神分裂症患者中重度(每天≥ 1 包)和非重度(每天<1 包)吸烟者之间的差异。这项研究的数据来自马里兰州住院精神卫生机构(1994-2000 年)收治的吸烟者人群中的 745 名患者,他们的平均年龄为 41.3+/-12.6 岁。记录被审查以获取人口统计学信息、诊断、药物、吸烟和物质使用情况。43%的患者被归类为重度吸烟者。重度和非重度组在年龄、GAF、体重或 BMI 方面没有差异。在种族、性别或抗精神病药物治疗方面也没有发现差异。然而,每天吸烟≥ 1 包的患者更有可能使用其他物质,如酒精(χ(2)=6.67,df=1,p=0.01)、可卡因(χ(2)=6.66,df=1,p=0.01)和其他物质(χ(2)=9.95,df=1,p=0.003),而非重度吸烟者。按吸烟类别,未发现大麻或海洛因使用的差异。控制年龄、种族、性别和 BMI 后,重度吸烟者的总胆固醇(190.7(51.6)mg/dL)高于非重度吸烟者(178.2 (43.0)mg/dL,p=0.03),但血糖或血压没有差异。重度吸烟可能是精神分裂症的一个特殊健康风险,需要大力进行戒烟或减少吸烟的努力。